GSK2831781

id: gsk2831781-251-2356103
title: GSK2831781
text: GSK2831781 is a monoclonal antibody being developed by GlaxoSmithKline (GSK) for autoimmune diseases. The antibody targets the T cell activation marker LAG-3, which is mainly expressed in inflamed tissues. In GSK's March 2015 Product development pipeline document the antibody is listed under 'Immuno-inflammation' candidates. GSK2831781 entered a Phase I clinical trial in psoriasis early in 2015.
brand slug: wiki
category slug: encyclopedia
description: Monoclonal antibody for autoimmune diseases
original url: https://en.wikipedia.org/wiki/GSK2831781
date created:
date modified: 2023-08-12T09:04:31Z
main entity: {"identifier":"Q19904145","url":"https://www.wikidata.org/entity/Q19904145"}
image:
fields total: 13
integrity: 14

Related Entries

Explore Next Part